Clinical Trials
4 trialsNCT03426891 2025-10-06
Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT06283927 2024-02-28
RECSUR
Erasmus Medical Center
Recruiting
NCT02197169 2018-07-16
TARGET-I
DNAtrix, Inc.
Phase 1 Completed